Cybin Reports First Quarter Fiscal Year 2025 Financial Results and Recent Business Highlights

– Phase 3 multinational study of CYB003 expected to begin in late summer 2024 – – 30 clinical sites selected across the United States and Europe for Phase 3 CYB003 study – – 12-month efficacy results from Phase 2 study o

By: financialpost.com

Aug 08 2024
0
0 Views

Base Carbon Announces Receipt of US$11.2 Million From Sale of Carbon Credits

Orezone Closes C$64.9 Million Non-Brokered Private Placement

Cybin Reports First Quarter Fiscal Year 2025 Financial Results and Recent Business Highlights

Cresco Labs Reports Consistent Profitability Improvement with Second Quarter 2024 Financial Results

Dentalcorp Reports Second Quarter 2024 Results

Bombardier Partners with Alinghi Red Bull Racing, Uniting Sky and Sea

Recursion and Exscientia Enter Definitive Agreement to Create a Global Technology-Enabled Drug Discovery Leader with End-to-End Capabilities

illumin Reports Second Quarter 2024 Financial Results

Li-Cycle Reports Second Quarter 2024 Operational and Financial Results, Including Record Quarterly Revenue

Docebo Reports Second Quarter 2024 Results

ATS Reports First Quarter Fiscal 2025 Results

Banxico Faces Tough Rate Decision, Peru Seen Holding: Day Guide

Share this page

Guest Posts by Easy Branches

anchor links ads by Easy Branches

Get Reliable Matka Guessing Forum with our Satta Matka Expert and Get all Matka Chart For Free.

Cybin Reports First Quarter Fiscal Year 2025 Financial Results and Recent Business Highlights

Related